People with rheumatoid arthritis (RA) are at a higher risk for infections, including COVID-19, the novel coronavirus that has caused the current worldwide pandemic. COVID-19 is a highly infectious virus that spreads through airborne respiratory droplets. This increased vulnerability is attributed to the immune system alterations caused by RA and its treatments.
A significant study, as reported by Verywell Health, involved 582 patients with rheumatoid arthritis and 2,875 matched comparators, all of whom had COVID-19. The study found that people with RA had a 25% increased risk of contracting COVID-19 and a 35% higher likelihood of hospitalization or death due to COVID-19 compared to those without the disease. These findings, published in the journal Arthritis & Rheumatology, underscore the need for heightened precautions for individuals with RA during the pandemic.
Furthermore, Hospital for Special Surgery emphasizes the importance of COVID-19 vaccines for people with rheumatoid arthritis. Vaccination is recommended to mitigate the risks associated with COVID-19 in this vulnerable population.
In some cases, post-COVID-19 symptoms include arthralgia and arthritis, as reported in The Lancet Rheumatology. This emphasizes the complex interaction between COVID-19 and rheumatologic conditions.
Additionally, managing rheumatoid arthritis during the COVID-19 pandemic can be challenging. Medications commonly used in RA treatment may alter patients’ susceptibility to infection. This aspect is elaborated in a review featured on PubMed, discussing the impact of RA drugs on COVID-19 susceptibility and the recommended management strategies during these times.
Overall, the intersection of rheumatoid arthritis and COVID-19 presents unique challenges and risks. It is crucial for individuals with RA to follow recommended precautions, get vaccinated, and consult healthcare providers for tailored advice on managing their condition during the pandemic.
